Cargando…

Efficacy of tocilizumab in anti‐ N ‐methyl‐ d‐asparate receptor encephalitis with Graves' hyperthyroidism and positive anti‐glial fibrillary acidic protein antibodies

Detalles Bibliográficos
Autores principales:	Zhang, Yin‐Xi, Cai, Meng‐Ting, Li, Er‐Chuang, Xu, Yong‐Feng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Letters to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9532906/ https://www.ncbi.nlm.nih.gov/pubmed/36028930 http://dx.doi.org/10.1111/cns.13949

Ejemplares similares

Parainfectious Anti-Glial Fibrillary Acidic Protein-Associated Meningoencephalitis
por: Joo, Jae Young, et al.
Publicado: (2022)

Comment on “Parainfectious Anti-Glial Fibrillary Acidic Protein-Associated Meningoencephalitis”
por: Ahn, Byoung June, et al.
Publicado: (2022)

Efficacy of Tocilizumab in Limbic Encephalitis with Anti-CASPR2 Antibodies
por: Benucci, Maurizio, et al.
Publicado: (2020)

Pharmacodynamic Response to Anti-thyroid Drugs in Graves' Hyperthyroidism
por: Abbara, Ali, et al.
Publicado: (2020)

Re: Comment on “Parainfectious Anti-Glial Fibrillary Acidic Protein-Associated Meningoencephalitis”
por: Yoo, Dallah, et al.
Publicado: (2022)

Supratentorial hydrocephalus with an anti‐glial fibrillary acidic protein (GFAP) antibody‐positive status: A case report
por: Tang, Lei, et al.
Publicado: (2022)

In vitro Efficacy of Anti‐glial Fibrillary Acidic Protein Monoclonal Antibodies against Human Malignant Glioma Cell Lines
por: Abaza, Mohamed‐Salah I., et al.
Publicado: (1997)

Overlapping Autoimmune Syndromes in Patients With Glial Fibrillary Acidic Protein Antibodies
por: Yang, Xinguang, et al.
Publicado: (2018)

Autopsy Case of Meningoencephalomyelitis Associated With Glial Fibrillary Acidic Protein Antibody
por: Yamakawa, Mai, et al.
Publicado: (2021)

Isolated optic neuritis with positive glial fibrillary acidic protein antibody
por: Jia, Nan, et al.
Publicado: (2023)

Detection and significance of glial fibrillary acidic protein antibody in autoimmune astocytopathy and related diseases
por: Huang, Jiehong, et al.
Publicado: (2019)

Anti-glial fibrillary acidic protein antibodies as a cause of reversible splenial lesion syndrome (RESLES): a case report
por: Guo, Kundian, et al.
Publicado: (2021)

OR19-6 A Novel Anti-CD40 Monoclonal Antibody, Iscalimab, Successfully Treats Graves’ Hyperthyroidism
por: Kahaly, George, et al.
Publicado: (2019)

Modelling and Characterization of Glial Fibrillary Acidic Protein
por: Deka, Hemchandra, et al.
Publicado: (2015)

Autoimmune glial fibrillary acidic protein astrocytopathy
por: Kunchok, Amy, et al.
Publicado: (2019)

Clinical utility of serum glial fibrillary acidic protein in glial neoplasm
por: Yadav, Nidhi, et al.
Publicado: (2022)

Clinical diagnosis of Graves’ or non-Graves’ hyperthyroidism compared to TSH receptor antibody test
por: Bell, Lauren, et al.
Publicado: (2018)

Peripheral nervous system involvement accompanies central nervous system involvement in anti-glial fibrillary acidic protein (GFAP) antibody-related disease
por: Theuriet, Julian, et al.
Publicado: (2023)

Case Report: Semantic Variant of Primary Progressive Aphasia Associated With Anti-Glial Fibrillary Acid Protein Autoantibodies
por: Hansen, Niels, et al.
Publicado: (2022)

Glial fibrillary acidic protein in tumours of the nervous system.
por: Delpech, B., et al.
Publicado: (1978)

Glial fibrillary acidic protein is localized in the lens epithelium
Publicado: (1984)

The importance of an individual approach to Graves’ hyperthyroidism
por: Bednarczuk, Tomasz
Publicado: (2015)

Alternating hyperthyroidism and hypothyroidism in Graves’ disease
por: Wong, Mimi, et al.
Publicado: (2018)

New Therapeutic Horizons for Graves’ Hyperthyroidism
por: Lane, Laura C, et al.
Publicado: (2020)

R-CHOP-Associated Graves' Hyperthyroidism
por: Mora, Natalie, et al.
Publicado: (2019)

Toward Ultimate Care for Graves’ Hyperthyroidism
por: Azizi, Fereidoun, et al.
Publicado: (2019)

The Grave Hematologic and Hepatic Effects of Hyperthyroidism
por: Ahmad, Sara Miriam, et al.
Publicado: (2021)

Quantitation of glial fibrillary acidic protein in human brain tumours.
por: Rasmussen, S., et al.
Publicado: (1980)

Glial Fibrillary Acidic Protein-Expressing Glia in the Mouse Lung
por: Suarez-Mier, Gabriela B., et al.
Publicado: (2015)

Clinical Relevance of Cerebrospinal Fluid Antibody Titers in Anti-N-Methyl-d-Aspartate Receptor Encephalitis
por: Cai, Meng-Ting, et al.
Publicado: (2021)

Small vessel childhood primary angiitis of the central nervous system with positive anti-glial fibrillary acidic protein antibodies: a case report and review of literature
por: Datyner, E, et al.
Publicado: (2023)

Anti-adenylate kinase 5 encephalitis: Clinical characteristics, diagnosis, and management of this rare entity
por: Li, Er-Chuang, et al.
Publicado: (2023)

Current and emerging treatment options for Graves’ hyperthyroidism
por: Abraham, Prakash, et al.
Publicado: (2010)

Hyperthyroidism and Graves’ disease: Is an ultrasound examination needed?
por: Varadhan, Lakshminarayanan, et al.
Publicado: (2016)

The Influence of Prior Hyperthyroidism on Euthyroid Graves' Ophthalmopathy
por: Termote, Karolien, et al.
Publicado: (2014)

Graves’ hyperthyroidism in pregnancy: a clinical review
por: Nguyen, Caroline T., et al.
Publicado: (2018)

Selenium in the Treatment of Graves’ Hyperthyroidism and Eye Disease
por: Lanzolla, Giulia, et al.
Publicado: (2021)

Elevated vitreous body glial fibrillary acidic protein in retinal diseases
por: Jünemann, Anselm Gerhard Maria, et al.
Publicado: (2015)

Autoimmune Glial Fibrillary Acidic Protein Astrocytopathy: A Review of the Literature
por: Shan, Fulan, et al.
Publicado: (2018)

Abnormal evoked potentials in autoimmune glial fibrillary acidic protein astrocytopathy
por: Tokimura, Ryo, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_atbk5afnkag8gsrdg7kf31u5m7